(Q41349182)

29 September 2017

title

Respiratory syncytial virus infection in older adults: an under-recognized problem (English)

1 reference

29 September 2017

Angela R Branche

1

1 reference

29 September 2017

Ann R Falsey

series ordinal

2

1 reference

29 September 2017

publication date

1 April 2015

1 reference

29 September 2017

1 reference

29 September 2017

volume

32

1 reference

29 September 2017

issue

4

1 reference

29 September 2017

page(s)

261-269

1 reference

https://scigraph.springernature.com/pub.10.1007/s40266-015-0258-9

29 September 2017

exact match

0 references

cites work

Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Severity of respiratory syncytial virus infection is related to virus strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

The incidence and clinical burden of respiratory syncytial virus disease identified through hospital outpatient presentations in Kenyan children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus infection in elderly and high-risk adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus: an important cause of acute respiratory illness among young adults undergoing military training

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus infections in previously healthy working adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Simple method for combining sputum and nasal samples for virus detection by reverse transcriptase PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Bacterial complications of respiratory tract viral illness: a comprehensive evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus outbreak in a long-term care facility detected using reverse transcriptase polymerase chain reaction: an argument for real-time detection methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Acute respiratory tract infection in daycare centers for older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Hospitalizations for acute lower respiratory tract infection due to respiratory syncytial virus in Thailand, 2008-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus infection in Guatemala, 2007-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Viral etiology of influenza-like illnesses in Huizhou, China, from 2011 to 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory viruses associated with patients older than 50 years presenting with ILI in Senegal, 2009 to 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Evaluation of four methods for the diagnosis of respiratory syncytial virus infection in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Medically attended respiratory syncytial virus infections in adults aged ≥ 50 years: clinical characteristics and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Seasonal incidence of medically attended respiratory syncytial virus infection in a community cohort of adults ≥50 years old

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Serologic evidence of respiratory syncytial virus infection in nursing home patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

An outbreak of respiratory syncytial virus infection in a continuing-care geriatric ward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Acute upper respiratory tract viral illness and influenza immunization in homes for the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

An outbreak of an influenza-like illness in a nursing home

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Can respiratory syncytial virus and influenza A be distinguished clinically in institutionalized older persons?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

The potential influence of common viral infections diagnosed during hospitalization among critically ill patients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly and high-risk adults possible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Risk factors for respiratory syncytial virus illness among patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Risk factors for severe respiratory syncytial virus infection in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Infections with viruses in patients hospitalized with acute respiratory illness, Stockholm 1963-1967.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus in blood and marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus infection following hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory virus infections in stem cell transplant patients: the European experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus infection in immunocompromised adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Viral epidemiology of acute exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Role of viral infections in asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus and influenza A infections in the hospitalized elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Diagnostic assays for respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Detection of respiratory viruses in sputum from adults by use of automated multiplex PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Viral shedding and immune responses to respiratory syncytial virus infection in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Oral GS-5806 activity in a respiratory syncytial virus challenge study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Progress in the prevention and treatment of RSV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Progress and challenges in RSV prophylaxis and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Influenza- and RSV-associated hospitalizations among adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0258-9

Epidemiology of acute respiratory illness during an influenza outbreak in a nursing home. A prospective study.

21 January 2018

1 reference

12 December 2020

Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants

1 reference

12 December 2020

Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature.

1 reference

12 December 2020

Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease

1 reference

12 December 2020

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

12 December 2020

Association between respiratory syncytial virus hospitalizations in infants and respiratory sequelae: systematic review and meta-analysis

1 reference

12 December 2020

Viral Respiratory Infections in the Institutionalized Elderly: Clinical and Epidemiologic Findings

1 reference

12 December 2020

Outbreak of respiratory syncytial virus infection in the elderly

1 reference

12 December 2020

[Viral infections as a cause of chronic obstructive pulmonary disease (COPD) exacerbation]

1 reference

12 December 2020

Upper respiratory tract infection and serum antibody responses in nursing home patients

1 reference

12 December 2020

10.1007/S40266-015-0258-9

Identifiers

DOI

1 reference

Dimensions Publication ID

29 September 2017

1033375758

0 references

1 reference